The brain undergoes natural structural and functional decline during normal aging. We are interested in how genomic variation affects neuroanatomy, cognition and behavior, and how the interplay of these factors promotes vulnerability or resistance to neurodegeneration in diverse populations.
We take a two-pronged approach for investigating the role of genes in brain health:
- Elucidate how variation across the genome confers risk for neurodegenerative disease
- Identify genetic variation that promotes brain and cognitive resilience in aging
AFFILIATIONS
The Yokoyama lab lives within the Edward and Pearl Fein Memory and Aging Center in the Department of Neurology.
Our Motivation
Our own families and friends have been affected by neurogenerative disease, which motivates us even further to better understand the brain.
In the summer of 2019, we lost our dear friend and colleague, Dr. Rahul Desikan, to ALS. Rahul was an outstanding physician and scientist in the prime of his career and his life. He was only 41. We honor his memory, and the lives and memories of our families and friends affected by neurodegenerative disease, by relentlessly pursuing this research.
Our Mission
To develop and train the next generation of innovative researchers by uncovering new insights into the genetic contributions to neurodegeneration and healthy cognitive aging in diverse populations using genomics, transcriptomics, and neuroimaging methods.
Our Global Community
We study and represent diverse populations, and we recruit and work with people from diverse cultural, educational, and technical backgrounds, from all over the world.
Our Vision
A polygenic risk prediction and radiogenomic biomarker for every patient.